2025 Q3 -tulosraportti
Vain PDF
106 päivää sitten
Tarjoustasot
First North Denmark
Määrä
Osto
11 352
Myynti
Määrä
6 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 648 | - | - | ||
| 2 852 | - | - | ||
| 2 500 | - | - | ||
| 71 | - | - | ||
| 500 | - | - |
Ylin
1,445VWAP
Alin
1,305VaihtoMäärä
0,1 53 462
VWAP
Ylin
1,445Alin
1,305VaihtoMäärä
0,1 53 462
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 53 462 | 53 462 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 53 462 | 53 462 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 29.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·14 t sittenRemember to look at the volume before you panic, folks, the stock falls 10% on a trade of 2000 DKK.
·1 t sittenAgreed mojopete. I also hope that investors open their eyes to stenocare.
·1 päivä sittenTECHNICAL ANALYSIS – 4/2/2026 Good morning everyone! I promised to provide an update on the technical analysis, and it's been a while since the last one. Honestly, there isn't a whole lot new to add. Please refer back to my post from January 7th, where I, among other things, wrote that I would like to see the price test the 1.7 DKK zone soon. Already on January 12th, the price hit 1.68 DKK and was immediately rejected. This leads me to the volume profile of the stock's entire history. If you pull it from start to finish, it looks like this: 👉 https://www.tradingview.com/x/PmZavU4v/ Zoomed in: 👉 https://www.tradingview.com/x/qKLEx8bZ/ It is clearly visible here that the stock has effectively been range-bound since the end of August 2025, if one disregards the two price deviations that also appear on the chart. Otherwise, the price moves very clearly up and down within this channel. My bias has not changed. I still assess that there is a higher probability of an upward breakout. • Resistance: 1.7 DKK • Support: 1.3 DKK If we lose 1.3 DKK, the next support is still 1.3 DKK (range low), and then around 1.0 DKK. Conversely, I still believe that a clear break above 1.7 DKK could lead to a very rapid upward move. Have a good day!
·29.1.Yesterday, Analyst Group had a comment on the new partnership with WEECO Pharma GmbH. In summary, Analyst Group views STENOCARE's partnership with WEECO Pharma and the launch of the WEECO ASTRUM 10-10 extract in Germany as a strategically important step to accelerate the commercialization of the company's premium Astrum oil. By leveraging WEECO's established position, regulatory expertise, and sales and distribution capabilities in the German medical cannabis market, STENOCARE is expected to increase awareness, market penetration, and prescription activity for Astrum oil. Germany represents one of the largest and most important markets for medical cannabis in Europe, making a successful rollout a key value creator going forward. You can read the full analysis by clicking on the link https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-weeco-and-launch-of-a-new-astrum-oil-product-in-germany/
·28.1. · MuokattuHmm, I can't quite figure out if there's any substance to the announced agreement. When I search for: Weeco Pharma gmbh, there is also weeco holding, and furthermore also weeco aps in vodskov, all started in 2019. Weeco gmbh is parent company to weeco aps. A bankruptcy petition was filed by weeco aps in 2024. So far I haven't succeeded in finding any figures for weeco gmbh, apart from them getting 1 new investor in 2024.
·30.1.Well, a deal that could be seen for about 24 hours and then everything fell back ... Sigh- ·28.1.I have highlighted the reason why Stenocare expects the Astrum oil to be an economic success in Germany. STENOCARE's new Astrum oil addresses all these problems, as it is based on new innovative oil technology. The product differentiates STENOCARE as a pioneer in the next generation of medical cannabis, providing improved, consistent, and faster absorption into the bloodstream. Link to analyst group https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-weeco-and-launch-of-a-new-astrum-oil-product-in-germany/·28.1.If I'm going to spend effort on you, then I'd like to know if you have shares in Stenocare
·28.1.Not for now - considering taking a position before the next financial report, or at least before 26Q1 Canngros will be what drives the growth, and the question is whether it can already be seen in the next report, or if we need to go forward one more time before
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
106 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·14 t sittenRemember to look at the volume before you panic, folks, the stock falls 10% on a trade of 2000 DKK.·1 t sittenAgreed mojopete. I also hope that investors open their eyes to stenocare.
- ·1 päivä sittenTECHNICAL ANALYSIS – 4/2/2026 Good morning everyone! I promised to provide an update on the technical analysis, and it's been a while since the last one. Honestly, there isn't a whole lot new to add. Please refer back to my post from January 7th, where I, among other things, wrote that I would like to see the price test the 1.7 DKK zone soon. Already on January 12th, the price hit 1.68 DKK and was immediately rejected. This leads me to the volume profile of the stock's entire history. If you pull it from start to finish, it looks like this: 👉 https://www.tradingview.com/x/PmZavU4v/ Zoomed in: 👉 https://www.tradingview.com/x/qKLEx8bZ/ It is clearly visible here that the stock has effectively been range-bound since the end of August 2025, if one disregards the two price deviations that also appear on the chart. Otherwise, the price moves very clearly up and down within this channel. My bias has not changed. I still assess that there is a higher probability of an upward breakout. • Resistance: 1.7 DKK • Support: 1.3 DKK If we lose 1.3 DKK, the next support is still 1.3 DKK (range low), and then around 1.0 DKK. Conversely, I still believe that a clear break above 1.7 DKK could lead to a very rapid upward move. Have a good day!
- ·29.1.Yesterday, Analyst Group had a comment on the new partnership with WEECO Pharma GmbH. In summary, Analyst Group views STENOCARE's partnership with WEECO Pharma and the launch of the WEECO ASTRUM 10-10 extract in Germany as a strategically important step to accelerate the commercialization of the company's premium Astrum oil. By leveraging WEECO's established position, regulatory expertise, and sales and distribution capabilities in the German medical cannabis market, STENOCARE is expected to increase awareness, market penetration, and prescription activity for Astrum oil. Germany represents one of the largest and most important markets for medical cannabis in Europe, making a successful rollout a key value creator going forward. You can read the full analysis by clicking on the link https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-weeco-and-launch-of-a-new-astrum-oil-product-in-germany/
- ·28.1. · MuokattuHmm, I can't quite figure out if there's any substance to the announced agreement. When I search for: Weeco Pharma gmbh, there is also weeco holding, and furthermore also weeco aps in vodskov, all started in 2019. Weeco gmbh is parent company to weeco aps. A bankruptcy petition was filed by weeco aps in 2024. So far I haven't succeeded in finding any figures for weeco gmbh, apart from them getting 1 new investor in 2024.·30.1.Well, a deal that could be seen for about 24 hours and then everything fell back ... Sigh
- ·28.1.I have highlighted the reason why Stenocare expects the Astrum oil to be an economic success in Germany. STENOCARE's new Astrum oil addresses all these problems, as it is based on new innovative oil technology. The product differentiates STENOCARE as a pioneer in the next generation of medical cannabis, providing improved, consistent, and faster absorption into the bloodstream. Link to analyst group https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-weeco-and-launch-of-a-new-astrum-oil-product-in-germany/·28.1.If I'm going to spend effort on you, then I'd like to know if you have shares in Stenocare·28.1.Not for now - considering taking a position before the next financial report, or at least before 26Q1 Canngros will be what drives the growth, and the question is whether it can already be seen in the next report, or if we need to go forward one more time before
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
11 352
Myynti
Määrä
6 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 648 | - | - | ||
| 2 852 | - | - | ||
| 2 500 | - | - | ||
| 71 | - | - | ||
| 500 | - | - |
Ylin
1,445VWAP
Alin
1,305VaihtoMäärä
0,1 53 462
VWAP
Ylin
1,445Alin
1,305VaihtoMäärä
0,1 53 462
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 53 462 | 53 462 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 53 462 | 53 462 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 29.11.2024 |
2025 Q3 -tulosraportti
Vain PDF
106 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 29.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·14 t sittenRemember to look at the volume before you panic, folks, the stock falls 10% on a trade of 2000 DKK.·1 t sittenAgreed mojopete. I also hope that investors open their eyes to stenocare.
- ·1 päivä sittenTECHNICAL ANALYSIS – 4/2/2026 Good morning everyone! I promised to provide an update on the technical analysis, and it's been a while since the last one. Honestly, there isn't a whole lot new to add. Please refer back to my post from January 7th, where I, among other things, wrote that I would like to see the price test the 1.7 DKK zone soon. Already on January 12th, the price hit 1.68 DKK and was immediately rejected. This leads me to the volume profile of the stock's entire history. If you pull it from start to finish, it looks like this: 👉 https://www.tradingview.com/x/PmZavU4v/ Zoomed in: 👉 https://www.tradingview.com/x/qKLEx8bZ/ It is clearly visible here that the stock has effectively been range-bound since the end of August 2025, if one disregards the two price deviations that also appear on the chart. Otherwise, the price moves very clearly up and down within this channel. My bias has not changed. I still assess that there is a higher probability of an upward breakout. • Resistance: 1.7 DKK • Support: 1.3 DKK If we lose 1.3 DKK, the next support is still 1.3 DKK (range low), and then around 1.0 DKK. Conversely, I still believe that a clear break above 1.7 DKK could lead to a very rapid upward move. Have a good day!
- ·29.1.Yesterday, Analyst Group had a comment on the new partnership with WEECO Pharma GmbH. In summary, Analyst Group views STENOCARE's partnership with WEECO Pharma and the launch of the WEECO ASTRUM 10-10 extract in Germany as a strategically important step to accelerate the commercialization of the company's premium Astrum oil. By leveraging WEECO's established position, regulatory expertise, and sales and distribution capabilities in the German medical cannabis market, STENOCARE is expected to increase awareness, market penetration, and prescription activity for Astrum oil. Germany represents one of the largest and most important markets for medical cannabis in Europe, making a successful rollout a key value creator going forward. You can read the full analysis by clicking on the link https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-weeco-and-launch-of-a-new-astrum-oil-product-in-germany/
- ·28.1. · MuokattuHmm, I can't quite figure out if there's any substance to the announced agreement. When I search for: Weeco Pharma gmbh, there is also weeco holding, and furthermore also weeco aps in vodskov, all started in 2019. Weeco gmbh is parent company to weeco aps. A bankruptcy petition was filed by weeco aps in 2024. So far I haven't succeeded in finding any figures for weeco gmbh, apart from them getting 1 new investor in 2024.·30.1.Well, a deal that could be seen for about 24 hours and then everything fell back ... Sigh
- ·28.1.I have highlighted the reason why Stenocare expects the Astrum oil to be an economic success in Germany. STENOCARE's new Astrum oil addresses all these problems, as it is based on new innovative oil technology. The product differentiates STENOCARE as a pioneer in the next generation of medical cannabis, providing improved, consistent, and faster absorption into the bloodstream. Link to analyst group https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-weeco-and-launch-of-a-new-astrum-oil-product-in-germany/·28.1.If I'm going to spend effort on you, then I'd like to know if you have shares in Stenocare·28.1.Not for now - considering taking a position before the next financial report, or at least before 26Q1 Canngros will be what drives the growth, and the question is whether it can already be seen in the next report, or if we need to go forward one more time before
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
11 352
Myynti
Määrä
6 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 648 | - | - | ||
| 2 852 | - | - | ||
| 2 500 | - | - | ||
| 71 | - | - | ||
| 500 | - | - |
Ylin
1,445VWAP
Alin
1,305VaihtoMäärä
0,1 53 462
VWAP
Ylin
1,445Alin
1,305VaihtoMäärä
0,1 53 462
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 53 462 | 53 462 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 53 462 | 53 462 | 0 | 0 |